Video modal
popup modal
The MHICC is now Seriant !
The Montreal Health Innovations Coordinating Center (MHICC) is now Seriant.
Our new name reflects a bold step forward— expanding beyond cardiology and embracing innovations in clinical trials with a global reach.
While our identity has evolved, our commitment to operational excellence, client satisfaction, and quality remains the same.
Nidhal Lidiraa, MSc
Director of Business Development
Nidhal is a visionary leader and strategic thinker with over a decade of experience in sales, consulting, and business development within the biotechnology, pharmaceutical, and healthcare sectors. He has established a strong reputation for delivering customized strategic solutions that consistently exceed client expectations, leveraging data-driven insights. Furthermore, Nidhal has effectively led cross-functional teams to enhance service offerings, improve operational efficiencies, and achieve substantial revenue growth.
Before joining Seriant, Nidhal served as a Business Development Leader, accumulating extensive experience in relationship management, strategic account development, and business growth within the pharmaceutical and clinical research sectors. He is recognized as a customer-focused expert, renowned for establishing enduring client relationships, delivering exceptional services, and designing customized solutions to enhance client retention and satisfaction. Nidhal possesses strong skills in driving operational excellence and leading high-performing teams to exceed sales targets consistently. He has demonstrated expertise in managing high-value accounts, conducting successful negotiations, and achieving significant revenue growth.
He holds a Bachelor of Science degree in Molecular & Cellular Biology and a Master of Science degree in Immunology and is currently pursuing a Master of Business Administration (MBA) in Clinical Research & Management at Rushford Business School.
The integration of artificial intelligence and machine learning into clinical trials is poised to transform the industry significantly. To position Seriant for future success, Nidhal, in his capacity as Business Development Director, will advocate for strategic investments in these advanced technologies, thereby enhancing our data analysis capabilities and improving the efficiency of trials.
